Hu X, Zhang M, Xu J, Gao C, Yu X, Li X
Clin J Am Soc Nephrol. 2024; 19(12):1594-1602.
PMID: 39207845
PMC: 11637703.
DOI: 10.2215/CJN.0000000000000555.
Kashiv P, Malde S, Gupta S, Dubey S, Sejpal K, Pawar T
Cureus. 2024; 16(5):e61230.
PMID: 38939287
PMC: 11210330.
DOI: 10.7759/cureus.61230.
Ding Y, Yao Y, Wan L, Qu Z, Yu F
BMC Nephrol. 2024; 25(1):212.
PMID: 38937663
PMC: 11212182.
DOI: 10.1186/s12882-024-03649-0.
Wei X, Long M, Fan Z, Hou Y, Zhu X, Qu Z
Front Endocrinol (Lausanne). 2024; 15:1328579.
PMID: 38524629
PMC: 10958378.
DOI: 10.3389/fendo.2024.1328579.
Li J, Zhang J, Wang X, Zheng X, Gao H, Jiang S
Int J Gen Med. 2023; 16:1879-1889.
PMID: 37213477
PMC: 10195059.
DOI: 10.2147/IJGM.S407073.
The thickness of glomerular basement membrane predicts complete remission in primary membranous nephropathy.
Duan S, Sun L, Zhang C, Zeng M, Sun B, Yuan Y
Ren Fail. 2023; 45(1):2179335.
PMID: 36856323
PMC: 9980401.
DOI: 10.1080/0886022X.2023.2179335.
Clinicopathological features and prognosis of primary membranous nephropathy in combination with crescent.
Pan Y, Liu L, Chen W, Yang H, Zhang J, Wang Y
Int Urol Nephrol. 2023; 55(6):1523-1530.
PMID: 36622536
PMC: 10185626.
DOI: 10.1007/s11255-022-03457-1.
Intrarenal Single-Cell Sequencing of Hepatitis B Virus Associated Membranous Nephropathy.
Yu L, Lin W, Shen C, Meng T, Jin P, Ding X
Front Med (Lausanne). 2022; 9:869284.
PMID: 35935760
PMC: 9355751.
DOI: 10.3389/fmed.2022.869284.
Screening of Medications for Idiopathic Membranous Nephropathy Using Glomerular Whole-Genome Sequencing.
Hou Y, Li Y, Li W, Xiao Z
Comput Math Methods Med. 2022; 2022:9337088.
PMID: 35465008
PMC: 9023152.
DOI: 10.1155/2022/9337088.
Complement induces podocyte pyroptosis in membranous nephropathy by mediating mitochondrial dysfunction.
Wang H, Lv D, Jiang S, Hou Q, Zhang L, Li S
Cell Death Dis. 2022; 13(3):281.
PMID: 35351877
PMC: 8964685.
DOI: 10.1038/s41419-022-04737-5.
Mechanism of action of for treatment of idiopathic membranous nephropathy based on network pharmacology.
Shi H, Hou Y, Su X, Qiao J, Wang Q, Guo X
Ren Fail. 2022; 44(1):116-125.
PMID: 35172688
PMC: 8856020.
DOI: 10.1080/0886022X.2021.2024850.
How Times Have Changed! A Cornucopia of Antigens for Membranous Nephropathy.
Caza T, Al-Rabadi L, Beck Jr L
Front Immunol. 2021; 12:800242.
PMID: 34899763
PMC: 8662735.
DOI: 10.3389/fimmu.2021.800242.
Qualitative and Quantitative Dosage of the Anti M-Type Phospholipase A2 Receptor Autoantibody: One-Year Experience in Quebec's Reference Center.
Leclerc S, Benkirane K, Nadeau-Fredette A, Elftouh N, Lafrance J, Pichette V
Can J Kidney Health Dis. 2021; 8:20543581211052729.
PMID: 34721885
PMC: 8552399.
DOI: 10.1177/20543581211052729.
Clinical characteristics and outcomes of idiopathic membranous nephropathy with glomerular IgM deposits.
Yu-Zhu X, Na-Ya H, Ya-Gui Q, Xiong-Hui C, Zhi-Jian L, Wei C
Clin Exp Med. 2021; 22(3):455-464.
PMID: 34698950
DOI: 10.1007/s10238-021-00768-y.
Single-Cell Profiling Reveals Transcriptional Signatures and Cell-Cell Crosstalk in Anti-PLA2R Positive Idiopathic Membranous Nephropathy Patients.
Xu J, Shen C, Lin W, Meng T, Ooi J, Eggenhuizen P
Front Immunol. 2021; 12:683330.
PMID: 34135910
PMC: 8202011.
DOI: 10.3389/fimmu.2021.683330.
A New Chemiluminescence Immunoassay for Phospholipase A Receptor 1 Autoantibodies Allows Early Identification of Autoantibody Recurrence in Patients With Membranous Nephropathy.
Hoxha E, Stahl R, Reinhard L, Kuhnl A, Schlumberger W, Dahnrich C
Kidney Int Rep. 2021; 6(4):928-935.
PMID: 33912742
PMC: 8071618.
DOI: 10.1016/j.ekir.2020.12.034.
Single-nucleotide polymorphism rs4664308 in PLA2R1 gene is associated with the risk of idiopathic membranous nephropathy: a meta-analysis.
Yoshikawa M, Asaba K
Sci Rep. 2020; 10(1):13119.
PMID: 32753608
PMC: 7403323.
DOI: 10.1038/s41598-020-70009-x.
New risk score for predicting steroid resistance in patients with focal segmental glomerulosclerosis or minimal change disease.
Weng Q, Zhou Q, Tong J, Jin Y, Liu Y, Yu X
Clin Proteomics. 2020; 17:18.
PMID: 32514258
PMC: 7257237.
DOI: 10.1186/s12014-020-09282-x.
Clinical and Pathophysiological Insights Into Immunological Mediated Glomerular Diseases in Childhood.
Mastrangelo A, Serafinelli J, Giani M, Montini G
Front Pediatr. 2020; 8:205.
PMID: 32478016
PMC: 7235338.
DOI: 10.3389/fped.2020.00205.
Development of a Standardized Chemiluminescence Immunoassay for the Detection of Autoantibodies Against Human M-Type Phospholipase A2 Receptor in Primary Membranous Nephropathy.
Dahnrich C, Saschenbrecker S, Gunnarsson I, Schlumberger W, Ronco P, Debiec H
Kidney Int Rep. 2020; 5(2):182-188.
PMID: 32043032
PMC: 7000842.
DOI: 10.1016/j.ekir.2019.11.008.